» Articles » PMID: 36464200

Amazing Roles of Extrachromosomal DNA in Cancer Progression

Overview
Publisher Elsevier
Date 2022 Dec 4
PMID 36464200
Authors
Affiliations
Soon will be listed here.
Abstract

In cancers, extrachromosomal DNA (ecDNA) has gained renewed interest since its first discovery, presenting its roles in tumorigenesis. Because of the unique structure and genetic characteristics, extrachromosomal DNA shed new light on development, early diagnosis, treatment and prognosis of cancers. Occurs in cancer cells, extrachromosomal DNA, one dissociative circular extrachromosomal element, drives the amplification of oncogenes, promotes the transcription and lifts tumor heterogeneity to participate in tumorigenesis. Given its role act as messenger, extrachromosomal DNA is connected with drug resistance, tumor microenvironment, germline and aging. The diversity of space and time gives extrachromosomal DNA a crucial role in cancer progression that has been ignored for decades. Thus, in this review, we will focus on some unique information of extrachromosomal DNA and the regulation of oncogenes as well as its roles and possible mechanisms in tumorigenesis, which are of great significance for us to understand extrachromosomal DNA comprehensively in carcinogenic mechanism.

Citing Articles

Extrachromosomal DNA (ecDNA) in cancer: mechanisms, functions, and clinical implications.

Dong Y, He Q, Chen X, Yang F, He L, Zheng Y Front Oncol. 2023; 13:1194405.

PMID: 37448518 PMC: 10338009. DOI: 10.3389/fonc.2023.1194405.


Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon.

Pons G, Gallo-Oller G, Navarro N, Zarzosa P, Sansa-Girona J, Garcia-Gilabert L Cancers (Basel). 2023; 15(6).

PMID: 36980521 PMC: 10046350. DOI: 10.3390/cancers15061636.